Sienna Biopharmaceuticals Overview
- Founded
- 2010

- Status
- Public
- Employees
- 39

- Stock Symbol
- SNNAQ

- Investments
- 1
Sienna Biopharmaceuticals General Information
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Contact Information
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
Sienna Biopharmaceuticals Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$232K | 79.8K |
Sienna Biopharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Sep-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
---|---|---|---|---|
EV | (13,007) | 15,053 | 287,833 | |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (52,417) | (73,314) | (50,715) | (21,095) |
Net Income | (47,951) | (73,471) | (50,545) | (21,162) |
Total Assets | 43,492 | 107,306 | 136,847 | 62,377 |
Total Debt | 0 | 30,125 | 0 |
Sienna Biopharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request a free trialSienna Biopharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Sienna Biopharmaceuticals‘s full profile, request access.
Request a free trialSienna Biopharmaceuticals Comparisons
Industry
0000000
000000 0
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSienna Biopharmaceuticals Competitors (7)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Dermata | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
000000 000000 | Corporate Backed or Acquired | San Diego, CA | 000 | 000.00 | 000000000 | 000.00 |
000000 0000000 | Venture Capital-Backed | San Diego, CA | 000 | 00000 | 000000 - 000 | 00000 |
0000000 0000000000 | Private Equity-Backed | Pune, India | 000 | 000.00 | 000000000 | 000.00 |
000000 00000000000 | Venture Capital-Backed | Carlsbad, CA | 0 | 000.00 | 00000000000 | 000.00 |
Sienna Biopharmaceuticals Executive Team (18)
Sienna Biopharmaceuticals Board Members (15)
Name | Representing | Role | Since |
---|---|---|---|
Dennis Fenton Ph.D | Self | Board Member | 000 0000 |
Donna Janson | Self | Board Member | 000 0000 |
Erle Mast | Self | Board Member | 000 0000 |
Frederick Beddingfield III | Sienna Biopharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
James Hindman | Self | Board Member | 000 0000 |
Sienna Biopharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSienna Biopharmaceuticals Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 | 06-Dec-2016 | 000000000000000000 | 00000 | Biotechnology |